SAGE
SAGE Therapeutics Inc
Price:  
9.11 
USD
Volume:  
1,937,777.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SAGE Relative Valuation

-1932.7%
Upside

As of 2025-07-19, the Relative Valuation of SAGE Therapeutics Inc (SAGE) is (166.95) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.11 USD, the upside of SAGE Therapeutics Inc based on Relative Valuation is -1932.7%.

The range of the Relative Valuation is (140.24) - (224.91) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 21.2x - 39.7x 26.7x
Forward P/E multiples 24.8x - 47.5x 32.3x
Fair Price (140.24) - (224.91) (166.95)
Upside -1639.4% - -2568.8% -1932.7%
9.11 USD
Stock Price
(166.95) USD
Fair Price

SAGE Relative Valuation - Historical P/E Data

Date P/E
2025-07-18 -1.61
2025-07-17 -1.61
2025-07-16 -1.61
2025-07-15 -1.62
2025-07-14 -1.62
2025-07-11 -1.64
2025-07-10 -1.63
2025-07-09 -1.63
2025-07-08 -1.62
2025-07-07 -1.62
2025-07-03 -1.63
2025-07-02 -1.60
2025-07-01 -1.60
2025-06-30 -1.61
2025-06-27 -1.62
2025-06-26 -1.64
2025-06-25 -1.63
2025-06-24 -1.63
2025-06-23 -1.64
2025-06-20 -1.64
2025-06-18 -1.61
2025-06-17 -1.61
2025-06-16 -1.60
2025-06-13 -1.18
2025-06-12 -1.17
2025-06-11 -1.20
2025-06-10 -1.24
2025-06-09 -1.20
2025-06-06 -1.21
2025-06-05 -1.20
2025-06-04 -1.16
2025-06-03 -1.15
2025-06-02 -1.17
2025-05-30 -1.14
2025-05-29 -1.15
2025-05-28 -1.14
2025-05-27 -1.15
2025-05-23 -1.15
2025-05-22 -1.17
2025-05-21 -1.20
2025-05-20 -1.26
2025-05-19 -1.25
2025-05-16 -1.22
2025-05-15 -1.17
2025-05-14 -1.13
2025-05-13 -1.17
2025-05-12 -1.19
2025-05-09 -1.16
2025-05-08 -1.19
2025-05-07 -1.21